Vaccination continues worldwide, but when will the corona epidemic end? Moderna CEO Stephen Bensel responded
The world is still facing the Coronavirus pandemic. The Kovid-19 virus, which surfaced in Wuhan city of China in December 2019, has reached every part of the world. To defeat Corona, people are being rapidly vaccinated all over the world. However, new variants of the virus are increasing the concerns of governments. In such a situation, there is a question that people around the world are asking again and again that when will the corona epidemic end? In such a situation, the CEO of the top vaccine manufacturer has given the answer.
Vaccine maker Moderna's chief Stephen Bancel said on Wednesday that the coronavirus pandemic could end in just a year. He predicted this and said that it will be like the current situation of flu. Stephen Bensel said that if you look at the industry expansion of production capacity in the last six months, there should be enough doses available by the middle of next year. In this way all the people of the world can be vaccinated. During this time, as many booster doses are needed, they will also be available in that number.
Vaccine is very important for good winter: Bensal
Bensal said, those who do not get vaccinated, they will naturally immunize themselves, because the delta variant is very dangerous. In this way we will reach a flu-like situation. If you get vaccinated, you will have good winters. If you do not do this, then the chances of getting sick will increase and may have to be hospitalized. When he was asked when the world would return to normalcy, he said that looking at the situation today, I think it will take a year for this to happen. Bensal said that he hopes that the vaccine will be approved for infants soon.
Delta is testing the customized variants
Moderna's CEO said, the company's current booster has remained the same. But now the time has come to complete the trial of the vaccine to be prepared to compete with the delta variant. He said, we are currently testing the Delta optimized variant in clinical trials. They will form the basis of booster vaccination for 2022. We are also testing on Delta and Beta. He said that scientists believe that mutation of the virus is possible.